Invitrogen drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- Whole-genome landscapes of 1,364 breast cancers. (2026)
- The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. (2017)
- Alternative Polyadenylation Directs Tissue-Specific miRNA Targeting in Somatic Tissues. (2017)
- A role for human homologous recombination factors in suppressing microhomology-mediated end joining. (2016)
- Fragment Length of Circulating Tumor DNA. (2016)
- Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. (2016)
- A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation. (2014)
- Ultrasensitive detection of rare mutations using next-generation targeted resequencing. (2012)
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. (2011)
- Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. (2010)
- RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| invitrogen | drug | 40 | 44 |